Crown Reserve Acquisition Corp. I Announces the Pricing of $150,000,000 Initial Public Offering

Company Overview - Crown Reserve Acquisition Corp. I is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [2] - The company will focus on industries where it has core competencies, including pharma, medical technology, medical equipment, and healthcare IT [2] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit, expected to begin trading on Nasdaq under the ticker symbol "CRACU" on November 7, 2025 [1] - Each unit consists of one Class A ordinary share, one-half of one redeemable warrant, and a right to receive one-fifth of one Class A ordinary share upon the consummation of an initial business combination [1] - The offering is expected to close on November 10, 2025, subject to customary closing conditions, with underwriters granted a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments [1] Management Team - The management team is led by Prashant Patel as Chief Executive Officer and Chairman, and Eric Sherb as Chief Financial Officer and Director [3] - The Board includes members Michael Peterson, Donald G. Fell, Avinash Wadhwani, and Mayur Doshi [3] Advisory and Management Support - Polaris Advisory Partners, a division of Kingswood Capital Partners LLC, is acting as the sole book-running manager for the offering [4] - Thunder Rock Capital, LLC, a division of Finalis Securities LLC, acted as an advisor to the company's management team [4]